Cargando…

Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database

BACKGROUND: To explore the prognostic factors of survival in non-small cell lung cancer (NSCLC) patients using the competing risk analysis. METHODS: This was a retrospective cohort study. NSCLC patients with complete data were selected from the Surveillance, Epidemiology, and End Results (SEER) data...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, Zhang, Qin, Lv, Yantian, Li, Ning, Xu, Guopeng, Ruan, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745371/
https://www.ncbi.nlm.nih.gov/pubmed/36523301
http://dx.doi.org/10.21037/tcr-21-2114
_version_ 1784849138480840704
author Chen, Ying
Zhang, Qin
Lv, Yantian
Li, Ning
Xu, Guopeng
Ruan, Ting
author_facet Chen, Ying
Zhang, Qin
Lv, Yantian
Li, Ning
Xu, Guopeng
Ruan, Ting
author_sort Chen, Ying
collection PubMed
description BACKGROUND: To explore the prognostic factors of survival in non-small cell lung cancer (NSCLC) patients using the competing risk analysis. METHODS: This was a retrospective cohort study. NSCLC patients with complete data were selected from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015. Outcomes were censored, cancer-specific mortality in NSCLC, and other-cause mortality. Gray’s test was used in univariable analysis, and a multivariable Fine-Gray competing risk model with backward elimination was used to explore the prognostic factors of survival. The screened variables were incorporated into a random survival forest (RSF) model for the prediction of 1-, 3-, and 5-year survival in patients with NSCLC. Receiver operator characteristic (ROC) curves, calibration curves, the value of area under the curve (AUC), and decision curve analysis (DCA) were used to evaluate the performance. RESULTS: Totally 1,251 eligible patients were included, 678 (54.20%) patients were cancer-specific mortality, and 128 (10.23%) patients were other-cause mortality. The median follow-up time was 26 months. Age, primary site, N stage, M stage, surgery type, tumor size, and lymph nodes (LNs) count were included in the multivariable Fine-Gray model for further analysis (P<0.05). The six most important features (surgery type, tumor size, M stage, LNs count, N stage, and primary site) were included in the competing risk analysis using the RSF model. The value of AUC for predicting 1-, 3-, and 5-year survival in the testing set were 0.796, 0.804, and 0.792, respectively. Calibration curves were well-fitted. DCA curves showed that the RSF model had similar or greater clinical net benefits in survival compared with the 8th edition the American Joint Committee on Cancer (AJCC) staging. The good performance of the RSF model under different surgery types, T, N, and M stages. CONCLUSIONS: We conducted a competing risk analysis using the RSF model for predicting the 1-, 3-, and 5-year survival of NSCLC. We generated a web calculator (https://github.com/YingChen19/Prognostic-factors-of-long-term-survival-of-non-small-cell-lung-cancer), which could provide a convenient assessment and could help improve the prognosis and survival of NSCLC.
format Online
Article
Text
id pubmed-9745371
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-97453712022-12-14 Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database Chen, Ying Zhang, Qin Lv, Yantian Li, Ning Xu, Guopeng Ruan, Ting Transl Cancer Res Original Article BACKGROUND: To explore the prognostic factors of survival in non-small cell lung cancer (NSCLC) patients using the competing risk analysis. METHODS: This was a retrospective cohort study. NSCLC patients with complete data were selected from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015. Outcomes were censored, cancer-specific mortality in NSCLC, and other-cause mortality. Gray’s test was used in univariable analysis, and a multivariable Fine-Gray competing risk model with backward elimination was used to explore the prognostic factors of survival. The screened variables were incorporated into a random survival forest (RSF) model for the prediction of 1-, 3-, and 5-year survival in patients with NSCLC. Receiver operator characteristic (ROC) curves, calibration curves, the value of area under the curve (AUC), and decision curve analysis (DCA) were used to evaluate the performance. RESULTS: Totally 1,251 eligible patients were included, 678 (54.20%) patients were cancer-specific mortality, and 128 (10.23%) patients were other-cause mortality. The median follow-up time was 26 months. Age, primary site, N stage, M stage, surgery type, tumor size, and lymph nodes (LNs) count were included in the multivariable Fine-Gray model for further analysis (P<0.05). The six most important features (surgery type, tumor size, M stage, LNs count, N stage, and primary site) were included in the competing risk analysis using the RSF model. The value of AUC for predicting 1-, 3-, and 5-year survival in the testing set were 0.796, 0.804, and 0.792, respectively. Calibration curves were well-fitted. DCA curves showed that the RSF model had similar or greater clinical net benefits in survival compared with the 8th edition the American Joint Committee on Cancer (AJCC) staging. The good performance of the RSF model under different surgery types, T, N, and M stages. CONCLUSIONS: We conducted a competing risk analysis using the RSF model for predicting the 1-, 3-, and 5-year survival of NSCLC. We generated a web calculator (https://github.com/YingChen19/Prognostic-factors-of-long-term-survival-of-non-small-cell-lung-cancer), which could provide a convenient assessment and could help improve the prognosis and survival of NSCLC. AME Publishing Company 2022-11 /pmc/articles/PMC9745371/ /pubmed/36523301 http://dx.doi.org/10.21037/tcr-21-2114 Text en 2022 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Chen, Ying
Zhang, Qin
Lv, Yantian
Li, Ning
Xu, Guopeng
Ruan, Ting
Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database
title Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database
title_full Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database
title_fullStr Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database
title_full_unstemmed Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database
title_short Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database
title_sort prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the seer database
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745371/
https://www.ncbi.nlm.nih.gov/pubmed/36523301
http://dx.doi.org/10.21037/tcr-21-2114
work_keys_str_mv AT chenying prognosticfactorsofsurvivalinpatientswithnonsmallcelllungcanceracompetingriskmodelusingtheseerdatabase
AT zhangqin prognosticfactorsofsurvivalinpatientswithnonsmallcelllungcanceracompetingriskmodelusingtheseerdatabase
AT lvyantian prognosticfactorsofsurvivalinpatientswithnonsmallcelllungcanceracompetingriskmodelusingtheseerdatabase
AT lining prognosticfactorsofsurvivalinpatientswithnonsmallcelllungcanceracompetingriskmodelusingtheseerdatabase
AT xuguopeng prognosticfactorsofsurvivalinpatientswithnonsmallcelllungcanceracompetingriskmodelusingtheseerdatabase
AT ruanting prognosticfactorsofsurvivalinpatientswithnonsmallcelllungcanceracompetingriskmodelusingtheseerdatabase